Literature DB >> 30063064

Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ.

Huan He1, Yong Luo, Yang Qiao, Zeyu Zhang, Dong Yin, Jianguo Yao, Jiegen You, Ming He.   

Abstract

Doxorubicin (Dox) induces cardiotoxicity, thereby limiting its clinical application for chemotherapy of cancer. The mechanism of cardiotoxicity includes the production of excess intracellular ROS. 14-3-3s have been found to protect the myocardium against various types of injury. Curcumin (Cur) is a polyphenolic compound that is derived from turmeric and has multiple bioactivities, including anti-oxidative and radical-scavenging activities that exert cytoprotection. We hypothesize that the cardioprotective effects of Cur are exerted by regulating 14-3-3γ. To test the hypothesis, Dox-induced cardiotoxicity was used to establish an in vivo myocardial injury model in mice (in vivo) and primary cardiomyocytes (in intro). The effects of Cur were assessed by determining the heart rate and ECG's ST segments, as well as lactate dehydrogenase (LDH) and creatine kinase (CK) activities in the serum, caspase-3 activity, apoptosis rate, and histopathological changes of the myocardium (in vivo). In addition, cell viability, LDH, SOD, CAT, GPx, and caspase-3 activities, levels of ROS, MDA, and MMP, mPTP opening, and the apoptosis rate (in vitro) were evaluated. The expression of 14-3-3γ and Bcl-2 as well as the phosphorylation levels of Bad (S112) were determined by western blot analysis. Our results showed that Dox-induced injury to the myocardium was decreased by Cur treatment via upregulating the protein expression of 14-3-3γ in total protein and Bcl-2 expression on mitochondria, activating Bad (S112) phosphorylation, reducing the heart rate and ST segment, and reducing LDH and CK activities in the serum, thereby causing a reduction in caspase-3 activity, the apoptosis rate, and histopathological changes of the myocardium (in vivo). Furthermore, Dox treatment increased cell viability and MMP levels, decreased LDH and caspase-3 activity, ROS levels, mPTP opening, and the apoptosis rate (in vitro). However, the cardioprotective effects of Cur were attenuated by pAD/14-3-3γ-shRNA, an adenovirus that caused a knock-down of intracellular 14-3-3γ expression. In conclusion, this is the first study to demonstrate that Cur protected the myocardium against Dox-induced injury via upregulating 14-3-3γ expression, thereby promoting the translocation of Bcl-2 to mitochondria, suppressing oxidative stress, and improving mitochondrial function.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30063064     DOI: 10.1039/c8fo00466h

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  26 in total

Review 1.  Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents.

Authors:  Run Yang; Changming Tan; Masoud Najafi
Journal:  Inflammopharmacology       Date:  2021-11-23       Impact factor: 4.473

2.  miR-140-5p mediates bevacizumab-induced cytotoxicity to cardiomyocytes by targeting the VEGFA/14-3-3γ signal pathway.

Authors:  Xuan-Ying Chen; Wei-Lin Huang; Xiao-Ping Peng; Yan-Ni Lv; Jun-He Li; Jian-Ping Xiong
Journal:  Toxicol Res (Camb)       Date:  2019-09-05       Impact factor: 3.524

Review 3.  Therapeutic potential of IKK-β inhibitors from natural phenolics for inflammation in cardiovascular diseases.

Authors:  Peng Zhou; Fang Hua; Xiang Wang; Jin-Ling Huang
Journal:  Inflammopharmacology       Date:  2020-01-01       Impact factor: 4.473

Review 4.  Protective effects of curcumin on chemical and drug-induced cardiotoxicity: a review.

Authors:  Fatemeh Yarmohammadi; A Wallace Hayes; Gholamreza Karimi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-03-05       Impact factor: 3.000

Review 5.  Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects.

Authors:  Qing-Yu Zhang; Fei-Xuan Wang; Ke-Ke Jia; Ling-Dong Kong
Journal:  Front Pharmacol       Date:  2018-11-06       Impact factor: 5.810

6.  DiOHF Protects Against Doxorubicin-Induced Cardiotoxicity Through ERK1 Signaling Pathway.

Authors:  Danqi Chang; Hang Li; Cheng Qian; Yanggan Wang
Journal:  Front Pharmacol       Date:  2019-09-27       Impact factor: 5.810

7.  Attenuation of doxorubicin-induced cardiotoxicity by cryptotanshinone detected through association analysis of transcriptomic profiling and KEGG pathway.

Authors:  Le Li; Bin Wu; Qiangqiang Zhao; Jian Li; Yunfeng Han; Xiaohang Fan; Junli Dong; Pengcheng Li
Journal:  Aging (Albany NY)       Date:  2020-05-26       Impact factor: 5.682

8.  Schisandrol A Attenuates Myocardial Ischemia/Reperfusion-Induced Myocardial Apoptosis through Upregulation of 14-3-3θ.

Authors:  Shuaishuai Gong; Jincheng Liu; Shiyao Wan; Weiwei Yang; Yuanyuan Zhang; Boyang Yu; Fang Li; Junping Kou
Journal:  Oxid Med Cell Longev       Date:  2021-06-26       Impact factor: 6.543

Review 9.  Effects of doxorubicin-induced cardiotoxicity on cardiac mitochondrial dynamics and mitochondrial function: Insights for future interventions.

Authors:  Nichanan Osataphan; Arintaya Phrommintikul; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  J Cell Mol Med       Date:  2020-04-26       Impact factor: 5.310

10.  Iron Overload Damages the Endothelial Mitochondria via the ROS/ADMA/DDAHII/eNOS/NO Pathway.

Authors:  Huan He; Yang Qiao; Qing Zhou; Zhiqing Wang; Xuepiao Chen; Dan Liu; Dong Yin; Ming He
Journal:  Oxid Med Cell Longev       Date:  2019-11-12       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.